Julie Wilkinson

Utility of lyophilized PMA and ionomycin to stimulate lymphocytes in whole blood for immunological assays

The need to implement robust biomarkers in clinical trials has never been greater, and such efforts can be easily compromised by reagent instability or simple human error during assay set‐up. Many biotechnology and pharmaceutical companies are introducing efforts to conduct biomarker studies under more rigorous settings, and the use of plates or tubes pre‐loaded with stimulation or staining reagents could be of value for studies that involve flow cytometry.